Related Experiment Video

Updated: May 25, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
12:43

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Published on: August 16, 2016

Reduction of myocardial oxygen demand by controlling heart rate and hemodynamics simultaneously by novel circulatory

Masaru Sugimachi1, Kazunori Uemura, Toru Kawada

  • 1National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka 5658565, Japan. su91mach@ri.ncvc.go.jp

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
|January 19, 2012
PubMed

Insights

Researchers controlled heart rate to reduce cardiac oxygen consumption in dogs with heart failure. This approach maintained hemodynamics without compromising oxygen use, improving long-term outcomes.

Area of Science:

  • Cardiovascular physiology
  • Heart failure research
  • Medical device technology

Background:

  • Current treatments can restore hemodynamic parameters like blood pressure and cardiac output.
  • Long-term outcomes in heart failure necessitate integrated cardioprotective strategies.
  • Controlling heart rate is a potential avenue for improving cardiac efficiency.

Purpose of the Study:

  • To investigate the impact of heart rate control on cardiac oxygen consumption.
  • To determine if lowering heart rate can enhance cardioprotection in acute heart failure.
  • To assess the feasibility of maintaining hemodynamics while reducing cardiac workload.

Main Methods:

  • Simulation modeling to predict the effects of heart rate control.
  • Animal experimentation in dogs with induced acute heart failure.
  • Hemodynamic monitoring and measurement of cardiac oxygen consumption.

Main Results:

  • Lowering heart rate in conjunction with hemodynamic treatment significantly decreased cardiac oxygen consumption.
  • Hemodynamic stability was maintained despite the reduction in heart rate.
  • The combined approach demonstrated the possibility of preserving cardiac function without increasing oxygen demand.

Conclusions:

  • Integrating heart rate control with existing hemodynamic therapies offers a promising strategy for cardioprotection.
  • Bradycardia can be a valuable tool in managing acute heart failure by reducing myocardial oxygen demand.
  • This approach may lead to improved long-term outcomes for heart failure patients.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...